Literature DB >> 18395378

[Frequency and antibiotic susceptibility of bacteria identified in urine].

Y Sekhsokh1, M Chadli, S A El Hamzaoui.   

Abstract

OBJECTIVE: The authors had for aim to evaluate the frequency of isolation and the antibiotic susceptibility of bacteria responsible for urinary infections among in and out-patients.
METHODS: A retrospective study was carried out at the Microbiology Laboratory of the Mohammed-V Military Instruction Hospital in Rabat, on bacteria isolated from 896 positive cytobacteriologic examinations of urine, from January 1 to December 31, 2005.
RESULTS: Among the 7472 urinary samples, 896 answered the criteria of urinary infection (12%). Urinary infections were more frequent in in-patients (57.8%; sex-ratio F/M=1:16). Enterobacteria were the most frequent (85%) and especially Escherichia coli (44.7%). Gram positive bacteria (11.6%) were more frequently Staphylococcus saprophyticus (3.1%). E. coli was highly resistant to amoxicillin, and sulfamethoxazole, whereas quinolones and aminosides maintained a good activity and third generation cephalosporines remain active (97% of susceptibility). Among the enterobacteria present, 3.2% were resistant to third generation cephalosporines with extended spectrum betalactamase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395378     DOI: 10.1016/j.medmal.2008.02.003

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  2 in total

1.  Saccharothrix sp. PAL54, a new chloramphenicol-producing strain isolated from a Saharan soil.

Authors:  Adel Aouiche; Nasserdine Sabaou; Atika Meklat; Abdelghani Zitouni; Christian Bijani; Florence Mathieu; Ahmed Lebrihi
Journal:  World J Microbiol Biotechnol       Date:  2011-09-22       Impact factor: 3.312

2.  Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon.

Authors:  Carine Magoué Lonchel; Cécile Meex; Joseph Gangoué-Piéboji; Raphaël Boreux; Marie-Claire Okomo Assoumou; Pierrette Melin; Patrick De Mol
Journal:  BMC Infect Dis       Date:  2012-03-09       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.